Results 171 to 180 of about 809,703 (372)

Optimal endoscopic localization of colorectal neoplasms: a comparison of rural versus urban documentation practices. [PDF]

World J Surg Oncol, 2023
El-Kefraoui C, Johnson G, Singh H, Helewa RM.   +3 more
europepmc   +1 more source

Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study [PDF]

, 2009
Hermann Brenner, Michael Hoffmeister, Volker Arndt, C Stegmaier, L Altenhofen, Ulrike Haug   +5 more
openalex   +1 more source

[Role of p53 gene in colorectal neoplasms].

Il Giornale di chirurgia, 1998
A prospective study on the role of the p53 gene in sporadic colorectal neoplasms is presented and the level of mutant p53 protein was measured in the tissue removed during colonoscopy from: patients previously operated for colorectal malignant neoplasms, patients with active neoplasms, first degree relatives and during regular checks.
Forlini, A, Fusco, A, Nasrollah, N, Hribal, M, Paganelli, C, Gentileschi, P, Russo, F, Sica, G, Gaspari, A L   +8 more
openaire   +2 more sources

3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline

Advanced Healthcare Materials, EarlyView.
Minimal residual disease (MRD) leads to cancer relapse and poor survival in ovarian cancer. The lack of representative 3D models limits therapy development. The microfluidics‐based high throughput 3D microtumor platform described here generates clinically‐relevant MRD models. The 3D microtumors recapitulate the molecular signatures of MRD from patients.
Xingyun Yang, Mara Artibani, Yongcheng Jin, Aneesh Aggarwal, Yujia Zhang, Sandra Muñoz‐Galvan, Ellina Mikhailova, Lena Rai, Nobina Mukherjee, Ravinash Krishna Kumar, Ashwag Albukhari, Shaohua Ma, Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley   +14 more
wiley   +1 more source

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms. [PDF]

Front Oncol, 2023
Zeng T, Huang Z, Yu X, Zheng L, Liu T, Tian B, Xiao S, Huang J.   +7 more
europepmc   +1 more source

Analysis of Proliferative Activity of Cells in Superficial Type Lesions of Colorectal Neoplasms by Proliferating Cell Nuclear Antigen (PCNA) Staining: Comparison between Old Age and Pre-old Age Groups

, 2000
Toshiya Chiba, Masaaki Matsukawa, Masatoshi Nakamachi, Noboru HIRATSUIKA, Yoshifumi OONISHI   +4 more
openalex   +2 more sources

Response: Re: Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study [PDF]

, 2010
Hermann Brenner, Michael Hoffmeister, Volker Arndt, Ulrike Haug   +3 more
openalex   +1 more source

A Novel 3D High‐Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer

Advanced Healthcare Materials, EarlyView.
Ovarian cancer's high recurrence and therapy resistance demand new strategies. A high‐throughput drug screening pipeline using 3D spheroids, which showed poor concordance with 2D models, identified rapamycin as a promising candidate. In combination with cisplatin, rapamycin demonstrated significant in vitro and in vivo efficacy, highlighting the ...
Nazanin Karimnia, Amy L. Wilson, Brittany R. Doran, Jennie Do, Amelia Matthews, Gwo Y. Ho, Magdalena Plebanski, Thomas W. Jobling, Andrew N. Stephens, Maree Bilandzic   +9 more
wiley   +1 more source

Robotic natural orifice specimen extraction surgery versus conventional robotic resection for patients with colorectal neoplasms. [PDF]

Front Oncol, 2023
Li L, Liu K, Li T, Zhou J, Xu S, Yu N, Guo Z, Yao H.   +7 more
europepmc   +1 more source

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Advanced Healthcare Materials, EarlyView.
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das, Juan L. Vivero‐Escoto   +4 more
wiley   +1 more source